##gff-version 3
##sequence-region Q9HC98 1 313
Q9HC98	UniProtKB	Chain	1	313	.	.	.	ID=PRO_0000086427;Note=Serine/threonine-protein kinase Nek6	
Q9HC98	UniProtKB	Domain	45	310	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9HC98	UniProtKB	Nucleotide binding	51	59	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9HC98	UniProtKB	Region	1	44	.	.	.	Note=Interaction with ARHGAP33%2C ANKRA2%2C CDC42%2C PRDX3%2C RAD26L%2C RBBP6%2C RPS7 and TRIP4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20873783;Dbxref=PMID:20873783	
Q9HC98	UniProtKB	Region	267	270	.	.	.	Note=Interaction with APBB1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17512906;Dbxref=PMID:17512906	
Q9HC98	UniProtKB	Active site	172	172	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
Q9HC98	UniProtKB	Binding site	74	74	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9HC98	UniProtKB	Site	108	108	.	.	.	Note=Autoinhibitory	
Q9HC98	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12840024;Dbxref=PMID:12840024	
Q9HC98	UniProtKB	Modified residue	202	202	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12840024;Dbxref=PMID:12840024	
Q9HC98	UniProtKB	Modified residue	206	206	.	.	.	Note=Phosphoserine%3B by NEK9;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:12840024,ECO:0000269|PubMed:20873783;Dbxref=PMID:19369195,PMID:23186163,PMID:12840024,PMID:20873783	
Q9HC98	UniProtKB	Modified residue	210	210	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17512906;Dbxref=PMID:17512906	
Q9HC98	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_041798;Note=In isoform 2. M->MPRREVCWEAAHFRQEEQSLPRPRVRALVRLACRM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9HC98	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_041799;Note=In isoform 3. M->MGRRRPAPFRALVRLACRM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9HC98	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_041800;Note=In isoform 4. M->MEATGWDSRCSPGTQVRALVRLACRM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9HC98	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Loss of autophosphorylation and of kinase activity and induction of apoptosis%3B when associated with M-75. K->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14563848,ECO:0000269|PubMed:19001501;Dbxref=PMID:14563848,PMID:19001501	
Q9HC98	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Loss of autophosphorylation and of kinase activity and induction of apoptosis%3B when associated with M-74. K->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14563848,ECO:0000269|PubMed:19001501;Dbxref=PMID:14563848,PMID:19001501	
Q9HC98	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Increase in catalytic activity. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19941817;Dbxref=PMID:19941817	
Q9HC98	UniProtKB	Sequence conflict	88	88	.	.	.	Note=Q->W;Ontology_term=ECO:0000305;evidence=ECO:0000305	
